Skip to main content

Hereditary Leiomyomatosis and Renal Cell Cancer

Hereditary Leiomyomatosis and Renal Cell Cancer

HLRCC is a genetic condition that affects the skin, uterus and kidneys.

The HLRCC Foundation is dedicated to patient advocacy, awareness and research in Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC).

HLRCC at a glance

FH

HLRCC is caused by mutations in the FH gene, which provides instructions for making an enzyme called fumarate hydratase.

50%

HLRCC is inherited in an autosomal dominant pattern, which means that an affected individual has a 50% chance of passing the condition on to each of their children.

Early

Detecting kidney cancer early in individuals with HLRCC before it spreads can be life saving.

Find an HLRCC specialist

Community

You are not alone

“This is definitely a knowledge is power situation… if something does come up and we catch it early, it could be a curable event.”
Quoted in “Advances in Care Help Save Young HLRCC Patient,” NIH Record

Real stories

People living with HLRCC, in their own words.

Portrait of Laura Esfeller

Laura Esfeller

“I was diagnosed with stage IV type 2 papillary renal cell carcinoma a few days after I turned 29 years old…”

Read the story
Boxing gloves raised in a boxing ring

A Boxing Champ’s Biggest Fight

“The CT scan revealed an 8.8 cm mass in the upper-middle left kidney consistent with kidney cancer.”

Read the story
Portrait of Dr. Cheryl Bahar

Dr. Cheryl Bahar

“My 10-year-old daughter, Jadyn… underwent surgery on July 3rd, 2015…”

Read the story

Support our work

Support patient advocacy, awareness and research

The HLRCC Foundation is a 501(c)(3) nonprofit. Your gift helps patients and families find information, expert care and each other.
Donation form powered by Zeffy. EIN 92-3898938.
This is a staging enviroment